BIM(EL) is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine

ABSTRACTS: BACKGROUND: Arsenic trioxide (ATO) is reported to be an effective therapeutic agent in acute promyelocytic leukemia (APL) through inducing apoptotic cell death. Buthionine sulfoximine (BSO), an oxidative stress pathway modulator, is suggested as a potential combination therapy for ATO-ins...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Tanaka, Yukie, Komatsu, Takayuki, Shigemi, Hiroko, Yamauchi, Takahiro, Fujii, Yutaka
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2014
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4029189/
https://ncbi.nlm.nih.gov/pubmed/24428916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-27
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia